Posted by Michael Wonder on 06 Nov 2023
EMA publishes agenda for 6-9 November 2023 CHMP meeting
6 November 2023 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Azacitidine
- Paclitaxel
- Momelotinib dihydrochloride monohydrate
- Ranibizumab
- Rozanolixizumab
- Ustekinumab
